NCT07288723Completed
Chronic Kidney Disease : Role of Biological Factors and Apolipoprotein L1 Encoding Gene (APOL1)
Chronic Kidney Disease : Role of Biological Factors and Apolipoprotein L1 Encoding Gene
Source: ClinicalTrials.gov · Last updated 17 Dec 2025
Brief summary (registry, in English)
Chronic kidney disease (CKD) is a major global public health issue. The present project focuses on the role of apolipoprotein L1 (APOL1) in patients with stage 4 CKD (glomerular filtration rate between 15 and 29 mL/min/1.73 m²).
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 88 (actual)
- First submitted
- 14 Nov 2025
- Start date
- 6 Apr 2023
- Primary completion date
- 6 Apr 2025
- Lead sponsor
- Centre Hospitalier Universitaire de la Guadeloupe
- Diseases
- Chronic kidney disease
- NCT number
- NCT07288723
What you commit to
- Study type: Observational
- Participants enrolled: 88
- From 6 Apr 2023 to the primary completion date, 6 Apr 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Lab values
- For patients with CKD : at stage 4 (GFR \< than 30 ml / min / 1.73m2.), whatever the etiology of CKD, associated pathologies and treatments,
- For patients with normal renal function : serum creatinine \< 10 mg/l.
Other
- Patients 18 y and older, of both sexes, Afro Caribbeans
- Living in Guadeloupe
- Having been informed of objectives and constraints of the study and who have given their written consent.
Who the study is looking for
- Patients 18 y and older, of both sexes, Afro Caribbeans
- Living in Guadeloupe
- Having been informed of objectives and constraints of the study and who have given their written consent.
- For patients with CKD : at stage 4 (GFR \< than 30 ml / min / 1.73m2.), whatever the etiology of CKD, associated pathologies and treatments,
- For patients with normal renal function : serum creatinine \< 10 mg/l.
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| CHU de la Guadeloupe Coordinator of this site? Confirm its status | Pointe-à-Pitre | Guadeloupe | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.